We found that XCL1+ CD8+ T cells could communicate with NK and myeloid cells through CD99 and MIF signaling pathways to regulate the anti-tumor immunity of CD8+ T cell in HCC TME. The gene discussed is CD8A; the disease is hepatocellular carcinoma.